J Korean Med Sci.  2006 Oct;21(5):790-793. 10.3346/jkms.2006.21.5.790.

X-linked Opitz G/BBB Syndrome: Identification of a Novel Mutation and Prenatal Diagnosis in a Korean Family

• Cho HJ
• Shin MY
• Ahn KM
• Lee SI
• Kim HJ
• Ki CS
• Kim JW

• KMID: 1781893
• DOI: http://doi.org/10.3346/jkms.2006.21.5.790

Abstract

X-linked Opitz G/BBB syndrome (XLOS; MIM 300000) is a rare multiple congenital anomaly disorder that is characterized by facial anomalies, laryngeal/tracheal/esophageal defects and genitourinary abnormalities. XLOS is caused by mutations in the MID1 gene which encodes a microtubule-associated RING-Bbox-Coiled-coil (RBCC) protein. We recently found a four-year Korean male patient who was suspected of having XLOS. Mutation analysis of the MID1 gene in the patient and his mother demonstrated that the patient had a novel insertion mutation (c.1798_1799-insC), and his mother was a heterozygous carrier of the mutation. After identification of the causative mutation in this family, prenatal diagnosis of two consecutive fetuses were successfully undertaken. This is the first report on a genetically confirmed case of XLOS in Korea.

Keyword

Genetic Diseases, X-Linked; XLOS; MID1; Mutation; Prenatal Diagnosis; Abnormalities, Multiple

MeSH Terms

Transcription Factors/*genetics
Syndrome
*Prenatal Diagnosis
Nuclear Proteins/*genetics
*Mutation
Microtubule Proteins/*genetics
Male
Infant, Newborn
Humans
Genetic Diseases, X-Linked/*genetics
Female
Abnormalities, Multiple/diagnosis/*genetics

Figure

• 

  Fig. 1 Pedigree and sequence of proband and proband's mother with a MID1 mutation. (A) Pedigree of family in present study. Squares and circles represent males and females, respectively. Blackened symbols indicate individuals with X-linked Opitz syndrome confirmed by MID1 mutation analysis. Small black dots within the circle indicate carrier state confirmed by MID1 mutation analysis. (B) Direct sequencing of the MID1 gene shows overlapping peaks from the nucleotide c.1798A (arrow) in the proband's mother due to a heterozygous 1 bp insertion of cytosine (c.1798_1799insC; p.His600ProfsX12). The proband was hemizygous for the mutation.

Reference

1. Opitz JM, Guttenberger JE, Pellet JR. The G syndrome of multiple congenital anomalies. Birth Defects Orig Artic Ser (V). 1969. 2:95–102.

2. Opitz JM, Smith DW. The BBB syndrome. Familial telecanthus with associated congenital anomalies. Birth Defects Orig Artic Ser (V). 1969. 2:86–94.

3. Robin NH, Opitz JM, Muenke M. Opitz G/BBB syndrome: clinical comparisons of families linked to Xp22 and 22q, and a review of the literature. Am J Med Genet. 1996. 62:305–317.

4. Robin NH, Feldman GJ, Aronson AL, Mitchell HF, Weksberg R, Leonard CO, Burton BK, Josephson KD, Laxova R, Aleck KA, Allanson JE, Guion-Almeida ML, Martin RA, Leichtman LG, Price RA, Opitz JM, Muenke M. Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2. Nat Genet. 1995. 11:459–461.

5. Quaderi NA, Schweiger S, Gaudenz K, Franco B, Rugarli EI, Berger W, Feldman GJ, Volta M, Andolfi G, Gilgenkrantz S, Marion RW, Hennekam RC, Opitz JM, Muenke M, Ropers HH, Ballabio A. Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22. Nat Genet. 1997. 17:285–291.

6. Gaudenz K, Roessler E, Quaderi N, Franco B, Feldman G, Gasser DL, Wittwer B, Horst J, Montini E, Opitz JM, Ballabio A, Muenke M. Opitz G/BBB syndrome in Xp22: mutations in the MID1 gene cluster in the carboxy-terminal domain. Am J Hum Genet. 1998. 63:703–710.

7. Cox TC, Allen LR, Cox LL, Hopwood B, Goodwin B, Haan E, Suthers GK. New mutations in MID1 provide support for loss of function as the cause of X-linked Opitz syndrome. Hum Mol Genet. 2000. 9:2553–2562.

8. De Falco F, Cainarca S, Andolfi G, Ferrentino R, Berti C, Rodriguez Criado G, Rittinger O, Dennis N, Odent S, Rastogi A, Liebelt J, Chitayat D, Winter R, Jawanda H, Ballabio A, Franco B, Meroni G. X-linked Opitz syndrome: novel mutations in the MID1 gene and redefinition of the clinical spectrum. Am J Med Genet A. 2003. 120:222–228.

9. So J, Suckow V, Kijas Z, Kalscheuer V, Moser B, Winter J, Baars M, Firth H, Lunt P, Hamel B, Meinecke P, Moraine C, Odent S, Schinzel A, van der Smagt JJ, Devriendt K, Albrecht B, Gillessen-Kaesbach G, van der Burgt I, Petrij F, Faivre L, McGaughran J, McKenzie F, Opitz JM, Cox T, Schweiger S. Mild phenotypes in a series of patients with Opitz GBBB syndrome with MID1 mutations. Am J Med Genet A. 2005. 132:1–7.

10. Pinson L, Auge J, Audollent S, Mattei G, Etchevers H, Gigarel N, Razavi F, Lacombe D, Odent S, Le Merrer M, Amiel J, Munnich A, Meroni G, Lyonnet S, Vekemans M, Attie-Bitach T. Embryonic expression of the human MID1 gene and its mutations in Opitz syndrome. J Med Genet. 2004. 41:381–386.

11. Mnayer L, Khuri S, Al-Ali Merheby H, Meroni G, Elsas LJ. A structure-function study of MID1 mutations associated with a mild Opitz phenotype. Mol Genet Metab. 2006. 87:198–203.